Aptevo Therapeutics, Inc. (APVO)

6.66 -0.32 (-4.58%) USD  |  NASDAQ  |  Feb 20, 16:00
7.10 +0.44 (+6.61%) After-Hours: 20:00
More

Aptevo Therapeutics Price Target Std Dev

Price Target Std Dev Chart

View Price Target Std Dev for APVO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Std Dev Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Std Dev Range, Past 5 Years

View Price Target Std Dev Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Std Dev Benchmarks

View Price Target Std Dev Benchmarks
Start Trial
Johnson & Johnson Upgrade
Eli Lilly & Co. Upgrade
Dermata Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade